Verapamil Hci Injection
Product Images NDC 51662-1442

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Verapamil Hci (NDC 51662-1442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse Reactions (Adverse Reactions)

A data table listing adverse reactions caused by Verapamil HCl injection including symptomatic hypotension, bradycardia with AV block or asystole, and rapid ventricular rate due to WPW or LGL syndromes. It outlines proven effective treatments such as intravenous dopamine HCl, calcium chloride, norepinephrine bitartrate, isoproterenol HCl, atropine sulfate, cardiac pacing, DC-cardioversion, procainamide IV, and lidocaine HCl IV. Supportive treatments include intravenous fluids and Trendelenburg position as applicable.*

FDA Label Image

Dosage And Administration (Dosage And Administration)

This image shows dosing instructions for VERAPAMIL HCI injection in adults and pediatric patients. It details initial and repeat doses by weight and age groups, emphasizing intravenous bolus administration and dose limits for younger patients.*

FDA Label Image

How Supplied (How Supplied)

A data table listing vial sizes, NDC numbers, and carton sizes for injection products: 5-mg (2 ml) vials with NDC 51754-0203-2 in cartons of 5, 5-mg (2 ml) vials with NDC 51754-0203-4 in cartons of 25, and 10-mg (4 ml) vials with NDC 51754-0205-2 in cartons of 5.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of Verapamil HCl shown with molecular formula C27H38N2O4 · HCl and molecular weight 491.08. The diagram depicts the molecular connectivity of the compound including aromatic rings and functional groups.*

FDA Label Image

Serialized Labeling (Serialized Vial Labeling)

VERAPAMIL HCI Injection, USP 2.5 mg/mL is shown in a single-dose 2 mL vial. The vial label includes dosage strength and a purple band. The packaging label includes a barcode, serial numbers, and states distribution by HF Acquisition Co LLC in Mukilteo, WA. The vial is sealed with a gray flip-off cap.*

FDA Label Image

Vial Labeling (Vial Labeling)

VERAPAMIL HCl injection label showing 5 mg/2 mL (2.5 mg/mL) strength in a 2 mL single-dose vial. The label includes a warning to protect from light and specifies intravenous use only. Distributed and manufactured by Exela Pharma Sciences, Lenoir, NC. NDC code 51754-0203-1 is visible on the label along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.